Skip to main content
NCBI home page
Netherlands Heart Journal logoLink to Netherlands Heart Journal
. 2002 Jan;10(1):8–12.

Hybrid pharmacological and ablative therapy for the management of symptomatic atrial fibrillation

GP Kimman, T Szili-Torok, M Nieuwdorp, DAMJ Theuns, M Scholten, L Jordaens
PMCID: PMC2499668  PMID: 25696026

Abstract

Background

Hybrid therapy for atrial fibrillation class 1C and class III antiarrhythmic drugs (AAD) can convert atrial fibrillation (AF) into an isthmus-dependent atrial flutter (AFL) in more than 10% of patients. Hybrid pharmacological and ablative therapy offers a safe and effective approach to achieving and maintaining sinus rhythm. We evaluated the efficacy of this hybrid approach in the management of paroxysmal or persistent AF.

Methods

Eighteen patients with symptomatic AF treated with AAD and typical anticlockwise/clockwise AFL underwent radiofrequency (RF) ablation of AFL with an anatomical approach.

Results

RF ablation was successful in all patients. All but one patient continued with AAD. Four patients (22%) had recurrences of AFL. Two of them also had a recurrence of AF. Another three patients had recurrences of AF only, and finally, one patient developed an atrial tachycardia more than one year after the procedure. In conclusion, 11 patients (61%) did not experience recurrences of AF/AFL after tricuspid valve annulus (TV)-inferior caval vein (IVC) isthmus ablation with continuing antiarrhythmic drugs.

Conclusion

Hybrid pharmacological and ablative therapy is a safe and effective treatment for the management of patients with symptomatic AF.

Keywords: atrial fibrillation, hybrid therapy

Full text

PDF
8

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benjamin E. J., Levy D., Vaziri S. M., D'Agostino R. B., Belanger A. J., Wolf P. A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994 Mar 16;271(11):840–844. [PubMed] [Google Scholar]
  2. Blitzer M., Costeas C., Kassotis J., Reiffel J. A. Rhythm management in atrial fibrillation--with a primary emphasis on pharmacological therapy: Part 1. Pacing Clin Electrophysiol. 1998 Mar;21(3):590–602. doi: 10.1111/j.1540-8159.1998.tb00103.x. [DOI] [PubMed] [Google Scholar]
  3. Cauchemez B., Haissaguerre M., Fischer B., Thomas O., Clementy J., Coumel P. Electrophysiological effects of catheter ablation of inferior vena cava-tricuspid annulus isthmus in common atrial flutter. Circulation. 1996 Jan 15;93(2):284–294. doi: 10.1161/01.cir.93.2.284. [DOI] [PubMed] [Google Scholar]
  4. Cosio F. G., López-Gil M., Goicolea A., Arribas F., Barroso J. L. Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. Am J Cardiol. 1993 Mar 15;71(8):705–709. doi: 10.1016/0002-9149(93)91014-9. [DOI] [PubMed] [Google Scholar]
  5. Emori T., Fukushima K., Saito H., Nakayama K., Ohe T. Atrial electrograms and activation sequences in the transition between atrial fibrillation and atrial flutter. J Cardiovasc Electrophysiol. 1998 Nov;9(11):1173–1179. doi: 10.1111/j.1540-8167.1998.tb00089.x. [DOI] [PubMed] [Google Scholar]
  6. Fischer B., Haissaguerre M., Garrigues S., Poquet F., Gencel L., Clementy J., Marcus F. I. Radiofrequency catheter ablation of common atrial flutter in 80 patients. J Am Coll Cardiol. 1995 May;25(6):1365–1372. doi: 10.1016/0735-1097(95)00029-4. [DOI] [PubMed] [Google Scholar]
  7. Gallagher M. M., Camm A. J. Classification of atrial fibrillation. Pacing Clin Electrophysiol. 1997 Jun;20(6):1603–1605. doi: 10.1111/j.1540-8159.1997.tb03527.x. [DOI] [PubMed] [Google Scholar]
  8. Huang D. T., Monahan K. M., Zimetbaum P., Papageorgiou P., Epstein L. M., Josephson M. E. Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol. 1998 May;9(5):462–469. doi: 10.1111/j.1540-8167.1998.tb01837.x. [DOI] [PubMed] [Google Scholar]
  9. Kannel W. B., Abbott R. D., Savage D. D., McNamara P. M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982 Apr 29;306(17):1018–1022. doi: 10.1056/NEJM198204293061703. [DOI] [PubMed] [Google Scholar]
  10. Kimman G. P., van Hemel N. M., Jessurun E. R., van Dessel P. F., Kelder J. C., Defauw J. J., Guiraudon G. M. Comparison of late results of surgical or radiofrequency catheter modification of the atrioventricular node for atrioventricular nodal reentrant tachycardia. Eur Heart J. 1999 Apr;20(7):527–534. doi: 10.1053/euhj.1998.1337. [DOI] [PubMed] [Google Scholar]
  11. Kirkorian G., Moncada E., Chevalier P., Canu G., Claudel J. P., Bellon C., Lyon L., Touboul P. Radiofrequency ablation of atrial flutter. Efficacy of an anatomically guided approach. Circulation. 1994 Dec;90(6):2804–2814. doi: 10.1161/01.cir.90.6.2804. [DOI] [PubMed] [Google Scholar]
  12. Matsuo K., Kumagai K., Annoura M., Ideishi M., Arakawa K. Mechanism of antiarrhythmic effects of class Ic drugs in paroxysmal atrial fibrillation in man. Cardiology. 1998;89(2):119–123. doi: 10.1159/000006766. [DOI] [PubMed] [Google Scholar]
  13. Murdock C. J., Kyles A. E., Yeung-Lai-Wah J. A., Qi A., Vorderbrugge S., Kerr C. R. Atrial flutter in patients treated for atrial fibrillation with propafenone. Am J Cardiol. 1990 Sep 15;66(7):755–757. doi: 10.1016/0002-9149(90)91144-u. [DOI] [PubMed] [Google Scholar]
  14. Nabar A., Rodriguez L. M., Timmermans C., Smeets J. L., Wellens H. J. Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation. Am J Cardiol. 1999 Mar 1;83(5):785-7, A10. doi: 10.1016/s0002-9149(98)00992-8. [DOI] [PubMed] [Google Scholar]
  15. Nabar A., Rodriguez L. M., Timmermans C., van den Dool A., Smeets J. L., Wellens H. J. Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation: observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation. Circulation. 1999 Mar 23;99(11):1441–1445. doi: 10.1161/01.cir.99.11.1441. [DOI] [PubMed] [Google Scholar]
  16. Paydak H., Kall J. G., Burke M. C., Rubenstein D., Kopp D. E., Verdino R. J., Wilber D. J. Atrial fibrillation after radiofrequency ablation of type I atrial flutter: time to onset, determinants, and clinical course. Circulation. 1998 Jul 28;98(4):315–322. doi: 10.1161/01.cir.98.4.315. [DOI] [PubMed] [Google Scholar]
  17. Poty H., Saoudi N., Abdel Aziz A., Nair M., Letac B. Radiofrequency catheter ablation of type 1 atrial flutter. Prediction of late success by electrophysiological criteria. Circulation. 1995 Sep 15;92(6):1389–1392. doi: 10.1161/01.cir.92.6.1389. [DOI] [PubMed] [Google Scholar]
  18. Poty H., Saoudi N., Nair M., Anselme F., Letac B. Radiofrequency catheter ablation of atrial flutter. Further insights into the various types of isthmus block: application to ablation during sinus rhythm. Circulation. 1996 Dec 15;94(12):3204–3213. doi: 10.1161/01.cir.94.12.3204. [DOI] [PubMed] [Google Scholar]
  19. Pritchett E. L. Management of atrial fibrillation. N Engl J Med. 1992 May 7;326(19):1264–1271. doi: 10.1056/NEJM199205073261906. [DOI] [PubMed] [Google Scholar]
  20. Roithinger F. X., Karch M. R., Steiner P. R., SippensGroenewegen A., Lesh M. D. Relationship between atrial fibrillation and typical atrial flutter in humans: activation sequence changes during spontaneous conversion. Circulation. 1997 Nov 18;96(10):3484–3491. doi: 10.1161/01.cir.96.10.3484. [DOI] [PubMed] [Google Scholar]
  21. Schwartzman D., Callans D. J., Gottlieb C. D., Dillon S. M., Movsowitz C., Marchlinski F. E. Conduction block in the inferior vena caval-tricuspid valve isthmus: association with outcome of radiofrequency ablation of type I atrial flutter. J Am Coll Cardiol. 1996 Nov 15;28(6):1519–1531. doi: 10.1016/s0735-1097(96)00345-2. [DOI] [PubMed] [Google Scholar]
  22. Suttorp M. J., Kingma J. H., Koomen E. M., van 't Hof A., Tijssen J. G., Lie K. I. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol. 1993 Mar 15;71(8):710–713. doi: 10.1016/0002-9149(93)91015-a. [DOI] [PubMed] [Google Scholar]
  23. Tai C. T., Chen S. A., Chiang C. E., Lee S. H., Ueng K. C., Wen Z. C., Huang J. L., Chen Y. J., Yu W. C., Feng A. N. Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter. Circulation. 1997 Oct 21;96(8):2601–2611. doi: 10.1161/01.cir.96.8.2601. [DOI] [PubMed] [Google Scholar]
  24. Tai C. T., Chiang C. E., Lee S. H., Chen Y. J., Yu W. C., Feng A. N., Ding Y. A., Chang M. S., Chen S. A. Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction. J Cardiovasc Electrophysiol. 1999 Sep;10(9):1180–1187. doi: 10.1111/j.1540-8167.1999.tb00293.x. [DOI] [PubMed] [Google Scholar]
  25. Wijffels M. C., Kirchhof C. J., Dorland R., Allessie M. A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995 Oct 1;92(7):1954–1968. doi: 10.1161/01.cir.92.7.1954. [DOI] [PubMed] [Google Scholar]
  26. Yamashita T., Inoue H., Nozaki A., Kuo T. T., Usui M., Sugimoto T. Role of anisotropy in determining the selective action of antiarrhythmics in atrial flutter in the dog. Cardiovasc Res. 1992 Mar;26(3):244–249. doi: 10.1093/cvr/26.3.244. [DOI] [PubMed] [Google Scholar]

Articles from Netherlands Heart Journal are provided here courtesy of Springer

RESOURCES